ArticleEuropean heart journal open2025

Morning administration of anthracyclines is associated with a lower risk of cancer therapy-related cardiac dysfunction.

Markella I Printezi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.